News

RFK Jr.'s FDA officials overrode career staff to limit COVID shots
The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.
Jurnal Time2d
FDA Officials Overrode Staff on COVID Shots!
Senior officials at the Food and Drug Administration appointed by the Trump administration, under Health and Human Services ...
Science-Based Medicine2dOpinion
Dr. Vinay Prasad: Bodily Autonomy Applies to Raw Milk, Not Vaccines
This is what it looks like when disinformation doctors pretend to value data and science to further their true objective, ...
Red State Observer3d
FDA Official Defies COVID Mandates, Champions Personal Choice
FDA Vaccine Official Challenges COVID Vaccine Mandates** In a move that echoes the foundational principles of informed consent and personal choice, Dr. Vinay ...
MPR3d
FDA Eliminates REMS for CAR T-Cell Immunotherapies
Previously, due to the risk of cytokine release syndrome and neurological toxicities, many CAR T-cell therapies included a REMS requirement.
BioSpace3d
Kennedy Follows RSV Recommendations of ACIP Members He Fired
Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...
The Pharma Letter3d
FDA steps up assessment of myocarditis following mRNA COVID-19 jabs
The US Food and Drug Administration (FDA) has provided an update on the risk of myocarditis after receiving an mRNA COVID-19 ...
FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
FDA's Prasad overruled agency scientists in restricting use of COVID shots - report
FDA vaccines chief Vinay Prasad limited broader use of COVID vaccines, citing reduced risk and data concerns. Read more here.
Top FDA vaccine official rejected broad use of Covid-19 shots, documents show
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
Managed Healthcare Executive4d
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data
FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine ...
Iovance Biotherapeutics: ASCO Update, Competitor Data And The Road Ahead
IOVA's ASCO update reiterates the value of Amtagvi in melanoma, but upcoming data in lung cancer and endometrial cancer in H2'25 might have a bigger ...